MSH6 and ovarian carcinoma: Using the CPTAC dataset, we first explored the molecular mechanism of MSH6 protein in breast cancer, colon cancer, lung adenocarcinoma, clear cell renal cell carcinoma, ovarian cancer, and uterine corpus endometrial carcinoma from the perspective of total protein and phosphoprotein.